Harvard Bioscience Announces Second Quarter 2026 Financial Results

Go back to Harvard Bioscience Announces Second Quarter 2026 Financial Results
Harvard Bioscience, Inc. (NASDAQ: HBIO) Delayed: 7.55 +0.47 (6.64%)
Previous Close $7.08    52 Week High $3.90 
Open $6.94    52 Week Low $2.25 
Day High $7.63    P/E N/A 
Day Low $6.94    EPS $-0.03 
Volume 52,267